Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9614191.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co IncfiledCriticalMerck and Co Inc
Priority to GBGB9614191.6ApriorityCriticalpatent/GB9614191D0/en
Publication of GB9614191D0publicationCriticalpatent/GB9614191D0/en
Priority to CA002257206Aprioritypatent/CA2257206A1/en
Priority to AU33748/97Aprioritypatent/AU712057B2/en
Priority to JP10500782Aprioritypatent/JP2000511903A/en
Priority to EP97929769Aprioritypatent/EP0906310A4/en
Priority to PCT/US1997/009536prioritypatent/WO1997046556A1/en
GBGB9614191.6A1996-06-071996-07-05Oxadiazole benzenesulfonamides as selectives B3 agonists for the treatment of diabetes and obesity
PendingGB9614191D0
(en)